ShareValue scores for TTRX: Valuation 52, Quality 46, Growth 50, Health 56.

TTRX
NASDAQ

Turn Therapeutics Inc. Common Stock

$9.61(+1.91%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
52
Fair Value
Price vs Value
Quality
46
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
100
Bullish
Price Trend

Company Details

About

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026